Maquet to distribute Novadaq’s CO2 Heart Laser in U.S.
January 3, 2012 by leonardzehr · Leave a Comment
Novadaq Technologies (TSX:NDQ) has selected Maquet Cardiovascular, a unit of Sweden’s Getinge Group, as the exclusive distributor of its CO2 Heart Laser systems and procedure kits in the U.S. The CO2 Heart Laser System for Transmyocardial Revascularization (TMR) is indicated for use in patients suffering from severe angina that is not amenable to traditional medical [...]
Rodman starts Novadaq at outperform
June 21, 2011 by leonardzehr · Leave a Comment
Rodman & Renshaw has initiated coverage of Novadaq Technologies (TSX:NDQ) with a “market outperform” rating and 12-month price target of $6, saying the company’s SPY intra-operative fluorescent imaging technology represents a platform technology that could help in improving outcomes and / or reducing global costs using perfusion imaging. “Our valuation methodology employs a traditional discounted cash [...]
Riding the Next Wave
June 8, 2010 by leonardzehr · 1 Comment
No, we’re not talking about the north coast of Maui but rather a new research platform from long-time biotech analyst David Martin of Dundee Securities. “If I’m going to recommend that investors own a basket of biotech stocks, it makes sense that I ought to initiate on a basket of stocks rather than make one-off [...]
Novadaq gets second milestone from Intuitive
March 24, 2010 by stephenkilmer · Leave a Comment
Novadaq Technologies (TSX:NDQ) has received a $1 million payment from Intuitive Surgical (NASDAQ:ISRG) for achieving the second predefined milestone of their 2009 licence and development agreement. Under the agreement, Novadaq and Intuitive are working to integrate Novadaq’s proprietary SPY imaging technology into the 3D high definition imaging capabilities of Intuitive’s da Vinci surgical robotic system [...]



